Autonomix Medical Inc AMIX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
-
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
-
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
-
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
-
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
-
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
-
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
-
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award
Trading Information
- Previous Close Price
- $1.81
- Day Range
- $1.68–1.88
- 52-Week Range
- $1.81–32.55
- Bid/Ask
- $1.71 / $1.80
- Shares Outstanding
- 1.96M
- Market Cap
- $3.29M
- Volume/Avg
- 51,455 / 3M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 11
- Website
- https://www.autonomix.com
Valuation
|
Metric
|
AMIX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.31 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AMIX
|
|---|---|
Quick Ratio | 4.23 |
Current Ratio | 4.85 |
Interest Coverage | — |
Quick Ratio
AMIX
Profitability
|
Metric
|
AMIX
|
|---|---|
Return on Assets (Normalized) | −202.69% |
Return on Equity (Normalized) | −252.39% |
Return on Invested Capital (Normalized) | −256.86% |
Return on Assets
AMIX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|##rF<K! | LOCK|$@b& | $191B | |||
| Medtronic PLC
MDT
| LOCK|%sJ#WV | LOCK|W&^x$ | $127B | |||
| Stryker Corp
SYK
| LOCK|>cY^!W#w | LOCK|%& | $117B | |||
| Boston Scientific Corp
BSX
| LOCK|y<JdSD | LOCK|&!CDL | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|P&j%FF<c | LOCK|kW>k | $54B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|wl?%@@ | LOCK|^sS | $36B | |||
| DexCom Inc
DXCM
| LOCK|>bQy@n% | LOCK|zQK$P | $32B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|>>k | LOCK|%J# | $27B | |||
| Steris PLC
STE
| LOCK|@$%ZK@# | LOCK|yY^!? | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|N@%!W?x | LOCK|<W$ | $19B |
United States